Biotechnology Conference USA
34 results found
Promoted Events
AAPS National Biotechnology Conference
The 2012 AAPS National Biotechnology Conference presentations and discussions should be of interest to scientists who are devoted to advancing health through innovations in biotherapeutics. The scientific programming will feature 19 symposia, 16 roundtables and mini-symposia, 8 sunrise sessions and 3 short courses. All sessions are planned around the following themes: • Antibody Drug Conjugates • Bioanalysis • Biosimilar/Biobetters • Biotherapeutics Drug Development • Biotherapeutics Drug ...
more
All Events
Bio CEO & Investor Conference
The BIO CEO & Investor Conference is the largest investor conference focused on publicly traded biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
Our therapeutic workshops feature the latest information on pipeline innovation, and no other investor conference offers as many sessions involving MDs, CSOs, and industry analysts.
BIO One-on-One Partnering also provides an opportunity to arrange ...
more
TIPPA's International Pharmaceutical Publication Planning Annual Meeting
Hear top experts in the industry discuss the hottest issues effecting pharmaceutical publication planning today. TIPPA’s 10th Annual Meeting provides a forum for pharmaceutical communications professionals to discuss the current changes and challenges affecting publication planning, while promoting lively and constructive discourse from multiple perspectives. TIPPA's Executive Board of industry leaders has helped to design an agenda that will provide you with indispensible takeaways on ...
more
AIMBE Annual Event
Building a new economy through Medical and Biological Engineering: Improving Health and Creating Jobs in the Coming Decade
As our country continues to face a crisis impacting financial institutions and markets it is important for AIMBE to promulgate a vision for how medical and biological engineering will be part of the solutions. The 2012 Annual event will focus on the next crucial step, applied biological sciences, where the real future jobs and economic rewards lie for ...
more
Developing Scalable IT to Support Life Science Data
KEYNOTE SESSION: Getting More Value and Generating Knowledge from Large Volumes of Data and Studies
Generating More Knowledge from Our Data and More Value from Our Studies: The Value of Expert Skills
A major challenge in translational science is finding the relevant data, information and knowledge to allow meaningful correlation between pre-clinical observations and clinical outcomes. A big factor in this challenge is that the business drivers, processes, approaches, and cultures are very ...
more
Innovation Takes Root
2/20/2012
-
2/22/2012
Venue: Omni Orlando Resort, Orlando, USA
Categories:
Biotechnology
Whether you’re in product development, R&D, marketing or sales, Innovation Takes Root offers the latest ideas, strategies and developments around Ingeo and the biopolymer industry. Hear from the entire supply chain, from raw material suppliers, extruders, and converters, to brands and retailers. Speakers will be sharing their experience with developing, launching and marketing the latest eco-innovative products made from Ingeo biopolymer. Don’t miss out on this global forum for dialogue ...
more
Translational Science
Translational sciences can help increase not only the speed at which a drug reaches the clinic, but also the efficacy of the drug, the safety profile of that drug and the treatment population. Cambridge Healthtech Institute’s Eighth Annual Translational Science conference at the 2012 Molecular Med Tri-Con will bring scientists from academia, industry and government together to discuss the role of translational science in drug discovery and development. While remaining in the forefront of ...
more
Molecular Diagnostics
Technologies for molecular diagnostics are delivering new tools to the clinical community for faster and more accurate decision making. Learning what the demands of the community are, where the unmet medical need is, and how the assays can best perform, are critical questions to be asking. This meeting is the key conference for molecular diagnostics showcasing technologies and criteria for success such as market access and payment. It will encompass payers and reimbursement, ...
more
Personalized Diagnostics
Implementing clinical use of personalized diagnostics can stratify patients, give molecular classification of disease, determine the likelihood of occurrence, and recommend the best course of treatment. These approaches promise to reduce costs in healthcare, improve treatment, and have the potential to provide consumer-driven access to health information. Technologies will be evaluated for research and clinical use, and approaches for turning these discoveries into viable business ...
more
Oncology Clinical Trials
The recent breakthroughs in understanding of the molecular biology of cancer have led to an unprecedented number of new targets in oncology drug development. Many of these are already advancing to the clinical stages, making oncology clinical trials the most prevalent across therapeutic areas. The success of an oncology trial depends on many factors, the most important being the quality of pre-clinical data that provides a testable hypothesis. Biostatistical, scientific, organizational, ...
more
Process Validation for Biopharmaceuticals
2/27/2012
-
2/28/2012
Venue: Hilton San Diego Bayfront, San Diego, USA
Categories:
Biotechnology,
Science
The industry is moving towards a risk-based, lifecycle approach to process and analytical validation that will ensure continuous monitoring of the product pre and post-approval. IBC's Process and Product Validation conference will look at the industry's interpretation and implementation of FDA's new Process Validation Guidance, and will discuss how companies can successful integrate the new guidance into their existing validation programs....
more
Technology Transfer for Biopharmaceuticals
As biotech products progress from the simple to the complex, so do the demands of the clients for more higher-end, greater value-added activities from their manufacturing counterparts, whether internal or external.Transfers from lab to pilot plant or from clinical to commercial manufacturing have never been more challenging. Not only are there more regulatory oversight, shorter schedules and higher expectations, the suppliers network is more diverse than ever. Brought on by the major M&As over ...
more
Antibody Development and Production
Planning is now underway for Biopharmaceutical Development & Production week 2012, which will return to San Diego, CA and be held at the Hilton San Diego Bayfront on Feb. 29 - March 2. Join the Antibody Development & Production priority contact list for latest updates on this conference for 2012!...
more
Sequencing Data Analysis and Interpretation
The emergence and explosion high-throughput genomic platforms from microarrays, quantitative PCR, mass spec, and sequencing platforms have resulted in the extraordinary output of genomic data. Thus, the ability to analyze and interpret the data has rapidly become the rate limiting step. Cambridge Healthtech Institute’s Genomic Data Analysis and Interpretation combines unique perspectives from biological researchers, biostatisticians, and software developers, creating a common ground on which ...
more
X-Gen Congress and Exposition
3/5/2012
-
3/8/2012
Venue: Hilton San Diego Resort & Spa, San Diego, USA
Categories:
Biotechnology,
Genetics
Epigenetics:Exploring Effects...Environment...Expression Comprehending Copy Number and Structural Variation:Discovery...Data...Diseases...Diagnostics Targeting Non-Coding RNA:The Long and Short of IT Genomic Data Analysis and Interpretation:Turning Data into Knowledge ...
more